RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/22930730http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/22930730http://www.w3.org/2000/01/rdf-schema#comment"Ewing sarcoma is a rare but aggressive disease most common in young adults. This cancer is driven by a unique chimeric fusion oncogene but targeted strategies have been elusive. Here we report the identification of the protein kinase PKC-ß (PRKCB) as a disease-specific druggable target for treatment of Ewing sarcoma. We found that transcriptional activation of PRKCB was directly regulated by the chimeric fusion oncogene EWSR1-FLI1 that drives this cancer. PRKCB phosphorylated histone H3T6 to permit global maintenance of H3K4 trimethylation at a variety of gene promoters. PRKCB loss induced apoptosis in vitro and prevented tumor growth in vivo. Gene expression profiling revealed a strong overlap between genes modulated by EWSR1-FLI1 and PRKCB in regulating crucial signaling pathways. Taken together, our findings offer a preclinical proof-of-concept for PRKCB as a promising therapeutic target in Ewing sarcoma."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.org/dc/terms/identifier"doi:10.1158/0008-5472.can-12-0371"xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Pierron G."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Delattre O."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Tirode F."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Ballet S."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Lamoureux F."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Redini F."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Han Z.Y."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Perrin V."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Decouvelaere A.V."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Geoerger B."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"de Pinieux G."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Benetkiewicz M."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Daudigeos-Dubus E."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/author"Surdez D."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/date"2012"xsd:gYear
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/name"Cancer Res"xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/pages"4494-4503"xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/title"Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-beta abolishes ewing sarcoma growth."xsd:string
http://purl.uniprot.org/citations/22930730http://purl.uniprot.org/core/volume"72"xsd:string
http://purl.uniprot.org/citations/22930730http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/22930730
http://purl.uniprot.org/citations/22930730http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/22930730
http://purl.uniprot.org/uniprot/#_A9Z0R7-mappedCitation-22930730http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/22930730